<< Read Full Article

Analysts' Upgrades, Downgrades: DR Horton

Stock quotes in this article: FTO , SHLD , DHI , ENR , GENZ , NE , ALTR  

CHANGE IN RATINGS

DR Horton (DHI Quote) downgraded at Credit Suisse to Underperform. $7.50 price target. Stock is trading at a premium valuation in a tough selling climate.

Energizer (ENR Quote) upgraded at UBS from Sell to Neutral. Valuation call, as the stock is down 28% year-to-date. $40 price target.

Genzyme (GENZ Quote) downgraded at Citigroup from Buy to Hold. $61 price target. No visibility on Lumizyme approval, following the new 6-month delay. Estimates also lowered.

Noble (NE Quote) upgraded at Goldman Sachs to Buy from Neutral based on valuation. Shares are trading at 19% discount to peers based on EBITDA. Note that company is in strong position to make acquisitions during downcycle. Price target raised to $32 from $30. ...

<< Read Full Article

Recent Comments

Loading .....




Dow Jones S&P 500 NASDAQ 10-Year Note
10,452.68 1,109.24 2,185.03 33.23
Oil *
77.73
DOWN
18.90
UP
0.38
UP
9.22
UP
0.48
10 Yr
3.32%
SPDR Gold
119.18
-0.18%
+0.03%
+0.42%
+1.47%
Data delayed 20 minutes

Brokerage Partners

TheStreet Premium Services

All Services